Navigation Links
N.J. Woman Sues Johnson & Johnson's Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
Date:6/12/2012

ATLANTIC CITY, N.J., June 12, 2012 /PRNewswire/ -- A woman who suffered significant injuries after being implanted with a defective vaginal mesh patch has filed a lawsuit against New Brunswick, N.J.-based healthcare giant Johnson & Johnson (NYSE: JNJ) and a company subsidiary.

Attorneys from The Lanier Law Firm filed the complaint on June 11, 2012, for New Jersey resident Elizabeth Matthews against Johnson & Johnson and company subsidiary Ethicon Inc. of Somerville, N.J., in the Superior Court of New Jersey in Atlantic City. The case is Matthews v. Ethicon Inc., et al., No. ATL-L-4054-12.

Ms. Matthews was implanted with Ethicon's Gynecare Prolift and TVT Secur products during a surgical procedure performed in November 2007. After receiving the implants, she suffered various internal injuries and assorted health problems that persist to this day.

Earlier this month, Johnson & Johnson announced a request filed with the U.S. Food and Drug Administration (FDA) to stop selling the Gynecare Prolift, Prolift+ M, TVT Secur and Prosima surgical mesh products. In March, the FDA announced that Johnson & Johnson sold the Gynecare Prolift product for three years without proper regulatory approval. The FDA earlier ordered Johnson & Johnson and several other vaginal mesh implant manufacturers to study organ damage and other health problems associated with the products.

The Lanier Law Firm represents numerous victims of defective vaginal mesh implants in the mass tort litigation pending in New Jersey and the multidistrict litigation pending in the U.S. District Court for the Southern District of West Virginia. The firm currently is investigating potential legal claims involving similar products manufactured by Bard Medical, American Medical Systems and Boston Scientific.

Led by noted trial lawyer Mark Lanier, The Lanier Law Firm is widely recognized as one of the nation's top plaintiffs' law firms, including experience in cases involving dangerous pharmaceutical drugs, defective medical products and toxic exposure.

With offices in Houston, Los Angeles, New York, and Palo Alto, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions in courtrooms across the country. The firm is composed of outstanding trial attorneys with decades of experience handling cases involving pharmaceutical liability, asbestos exposure, intellectual property, business litigation, product liability, maritime law, bad faith insurance claims, and sports and entertainment law. Visit http://www.lanierlawfirm.com.

For more information on the vaginal mesh lawsuit against Johnson & Johnson, please contact J.D. Cargill at 713-659-5200.


'/>"/>
SOURCE The Lanier Law Firm
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
5. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
6. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
7. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
8. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
9. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
10. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
11. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):